Skip to main content

Table 3 Summary of multivariate analysis.

From: Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

Relapse-free survival

Variable

Hazard Ratio

95% CI

p value

Tumor size (mm)

1.031

[1.005-1.056]

0.018

Number of positive node

1.086

[1.030-1.155]

0.002

SBR grade 2 (ref. SBR1)

1.945

[0.551-6.871]

0.302

SBR grade 3 (ref. SBR1)

2.349

[0.628-8.794]

0.205

Estrogen receptor (negative)

1.527

[0.658-3.543]

0.325

Progesterone receptor (negative)

1.424

[0.6593-3.102]

0.374

CCR6+ tumor cells

1.929

[0.986-3.772]

0.055

CCL19+ DC

2.277

[1.141-3.772]

0.020

Overall Survival

Variable

Hazard Ratio

95% CI

p value

Tumor size (mm)

1.027

[1.006-1.049]

0.012

Number of positive node

1.118

[1.066-1.173]

< 0.001

SBR grade 2 (ref. SBR1)

1.534

[0.549-4.287]

0.415

SBR grade 3 (ref. SBR1)

1.931

[0.666-5.605]

0.226

Progesterone receptor (negative)

1.419

[0.751-2.678]

0.281

CCR6+ tumor cells

1.205

[0.638-2.277]

0.565

CCL19+ DC

1.717

[0.916-3.219]

0.092

  1. SBR: Scarff-Bloom-Richardson grade; ref.: reference for analysis; CCR6+: CCR6-positive; CCR19+ DC: CCR19-positive dendritic cells.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us